Coverage decisions for the treatment, called CAR T-cell therapy, had fallen to Medicare's regional administrators, which officials said caused confusion. Trump administration officials said the announcement would ensure patients have "consistent and predictable access" to a potentially lifesaving therapy. The treatment costs $375,000 or $475,000. Hospital stays can add hundreds of thousands of dollars to that. |
No comments:
Post a Comment